Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of

Authors :: Liza, Lindenberg
Esther, Mena
Baris, Turkbey
Joanna H, Shih
Sarah E, Reese
Stephanie A, Harmon
Ilhan, Lim
Frank, Lin
Anita, Ton
Yolanda L, McKinney
Philip, Eclarinal
Deborah E, Citrin
William, Dahut
Ravi, Madan
Bradford J, Wood
Venkatesh, Krishnasamy
Richard, Chang
Elliot, Levy
Peter, Pinto
Janet F, Eary
Peter L, Choyke
Source :: Radiology. 296(3)
Publication Year :: 2020
Abstract: Background Prostate cancer recurrence is found in up to 40% of men with prior definitive (total prostatectomy or whole-prostate radiation) treatment. Prostate-specific membrane antigen PET agents such as 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine 3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (

Subjects :: Male
Lysine
Positron Emission Tomography Computed Tomography
Prostate
Contrast Media
Humans
Prostatic Neoplasms
Urea
Prospective Studies
Middle Aged
Multiparametric Magnetic Resonance Imaging
Sensitivity and Specificity
Aged

Tools